Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 95
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The Down Low: Curbing the HIV Epidemic in Rural Louisiana

    African American men who have sex with men (MSMs) are at higher risk for new HIV infections in rural communities...

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    What is the role of the CLN1-CDK1 complex in the cell regulatory cycle of baker's yeast?

    In Saccharomyces cerevisiae, the protein CLN1 forms a complex with the CDK1 in the cell regulatory cycle. Studies...

    Backer Badge Funded